Gastroenterology
News from the FDA/CDC
FDA approves faster, pangenotypic cure for hep C virus
A faster cure for all genotypes of the hepatitis C virus with or without liver disease comes to market.
From the Journals
Inflammatory bowel disease rate higher among urban residents
As-yet unknown protective factors may be present in rural environments.
Applied Evidence
Radiation therapy: Managing GI tract complications
Here’s how to recognize radiation-related adverse effects so that you can expedite care and help preserve your patient’s quality of life.
From the Journals
Opioid use higher in adults with health conditions
Patients with cirrhosis are nearly twice as likely as are those without the condition to use prescription opioids.
News
FDA advisory panel backs safety of new hepatitis B vaccine for adults
A new, two-dose hepatitis B vaccine is given the nod of approval for further study.
From the Journals
CT scoring system may improve sacroiliitis treatment in IBD
Sacroiliitis is three times more prevalent among IBD patients and can be reliably detected in CT scans.
News
FDA approves new treatment for adults with HCV
Results of two trials showed that 96%-97% of patients who received Vosevi had no virus detected in the blood 12 weeks after finishing treatment
From the Journals
Liver cancer risk lower after sustained response to DAAs
DAAs may reduce prevalence of hepatocellular carcinoma among patients with hepatitis C.
From the Journals
New C. difficile drug shows promise
The antibiotic ridinilazole proved noninferior to vancomycin for treatment of Clostridium difficile infection, according to a new study...
From the Journals
Increased risk of death even in lower-risk PPI users
The mechanism of multiple risks in PPI users is still not known.
Latest News
Hospital isolates C. difficile carriers and rates drop
NEW ORLEANS – Screen for and isolate asymptomatic carriers.